• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Better For You Wellness Announces Results from Its February 5, 2022, Board of Directors Meeting

    2/10/22 3:58:00 PM ET
    $LEAF
    $PBH
    $SPTN
    EDP Services
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $LEAF alert in real time by email

    Better For You Wellness Establishes Strategic Advisory Committee with Industry Leaders and More

    Columbus, Ohio--(Newsfile Corp. - February 10, 2022) - Better For You Wellness, Inc. (OTCQB:BFYW) ("Better For You Wellness" or the "Company"), an Ohio-based company focused on the rapidly-growing $1.5T wellness industry, is pleased to announce the results of the Meeting of the Board of Directors that took place on February 5, 2022, via video conference (the "Board Meeting"). The seven members of the Company's Board of Directors (the "Board") include Ian James, Stephen Letourneau, Montel Williams, Christina Jefferson, Joseph Watson, David Deming, and Dr. Nicola Finley, MD.

    Establishment of Strategic Advisory Committee

    The Board unanimously approved the establishment of a Strategic Advisory Committee (the "Committee"). The Committee will be tasked with providing acceleration, reach, and guidance to further enhance the Company's value proposition and portfolio. The Committee will work closely with the Board and Better For You Wellness leadership and advise on matters relating to the Company's capital raising efforts, acquisitions, public relations strategy, brand development, international expansion, and more.

    Appointment of Committee Members

    In addition to the establishment of the Committee, the Board appointed six initial Committee Members by unanimous consent. The Committee is composed of respected industry leaders who bring relevant experience, networks, and leadership to the Company's various initiatives. These individuals reflect the Company's vision and dedication to building a global leader in the wellness sector. Committee Members include:

    • David King: King is currently a venture and private equity investor at Hairun Capital, a People's Republic of China and United States-based multi-family office that manages the investment assets of a group of high net worth Chinese and Chinese-American families. King currently serves on the Board of Directors of Genuine Health, a leading Canadian natural products company; AZTherapies, a Boston based drug discovery company targeting neuroinflammation and Alzheimer's Disease; Xylyx Bio, Inc., a New York-based drug discovery research tools company, Peak Capital, a New York and Taipei based private equity investment company; and Woodstone Holdings, a New York and Houston based investment company. Previously, King was a Co-Founder of Prestige Brands International, a US-listed personal care and consumer products company known as Prestige Consumer Healthcare Inc. (NYSE:PBH) following the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. Additionally, Kind was a Co-Founder and President of General Nutrition Centers ("GNC") China, a partner of Shanghai First Ventures, a Shanghai-based VC company affiliated with Bright Foods Group, and a Board Director of Tivoli Audio in Boston, Massachusetts. King started his career as an investment banker and was formerly Managing Director of PaineWebber Inc. in New York and Hong Kong, specializing in M&A and leveraged financings. He also served as Chairman of PaineWebber International (Asia) and oversaw the firm's Asian operations. King graduated from Yale University.

    • Laurie Racine: Racine currently serves as President of Racine Strategy, an advisory firm focused on the intersection of social responsibility, learning, media, and technology. Racine also currently serves on the Board of Advisors to the Global Wellness Institute, a global nonprofit organization with a mission to empower wellness worldwide by educating public and private sectors. The Board of Directors of Open Road Integrated Media, a digital media company and e-book publisher. Racine is also the Founder of dotSUB, a technology company that allows anyone to collaboratively re-purpose any video from one language into any other language. A Co-Founder of Thunkable, a commercial app creation tool based on and inspired by MIT's App Inventor. Racine formerly served as Director of the Health Sector Management Program at the Fuqua School of Business at Duke University and Senior Fellow at the Norman Lear Center of the Annenberg School of Communications at the University of Southern California. Additionally, Racine has served as an Advisor or Director to theSkimm, Creative Commons, CreatorUP, CITIA, LittleBits, WizeHive, the Tribeca Film Institute, Teachers Without Borders, and more. Racine received a B.A. from New York University and conducted coursework for a Ph.D. in Human Genetics at the University of California, Berkeley.

    • Zhiping "Stone" Zhang: Zhang currently serves as Managing Partner of Hairun Capital, a People's Republic of China and United States-based multi-family office that manages the investment assets of a group of high net worth Chinese and Chinese-American families. Zhang also currently serves as a Strategic Advisor to Xylyx Bio, Inc., a New York-based drug discovery research tools company. Formerly, Zhang served as Managing Director of Haiyin Capital, a Beijing, Hong Kong, and New York-based active investor in deep-tech sectors with global impact. Additionally, Zhang served as an Executive Director of DNV, an independent expert in risk management and assurance, operating in more than 100 countries. Zhang earned a B.A.Sc., M.Eng., Ph.D. from Harbin Engineering University, and an E.M.B.A. from the Jones Graduate School of Business at Rice University.
    • Melisse Gelula: Gelula was Co-Founder and former Chief Creative Officer for Well+Good, a wellness-focused media company that was acquired by Leaf Group Ltd. (NYSE:LEAF) in 2018. Gelula was honored by Inc. Magazine as one of the 9 Most Creative Entrepreneurs of 2018 and by AdWeek (June 2018), recognized as 10 Writers and Editors Who Are Changing the National Conversation. Gelula is also the former editor-in-chief of SpaFinderLifestyle.com, beauty director at Luxury SpaFinder Magazine, and travel editor at Fodor's Travel Publications. Gelula earned her B.A. from the University of Iowa and an M.A. from the University of Toronto.

    • Christopher Brown: Brown currently owns and operates CB, LLC, a consulting company working with leading private equity firms, retailers, and wholesalers. Before forming CB, LLC, Brown was former Senior Vice Price of Independent Sales at C&S Wholesale Grocers ("C&S"), is the largest wholesale grocery supplier in the United States. Before his role at C&S, Brown spent 11 years as EVP of Procurement/Merchandising and EVP of Food Distribution, before being named President and Chief Operating Officer of the Nash Finch Company, now a part of SpartanNash Co. (NASDAQ:SPTN) via merger. Brown graduated from Winona State University.

    • Kate Hendrickson: Hendrickson was a member of the 1992 U.S. Olympic kayaking team and an alternate in the 1996 Olympic Games, and a World Championship finalist and silver medalist at the 1995 Pan-American Games. Hendrickson was a founding member of the United States Anti-Doping Agency (the "USADA") Board of Directors, serving as an Athlete Representative and Secretary. Hendrickson was instrumental in establishing the TrueSport educational program for young athletes with the USADA. Hendrickson has also served as a member of the City of Charleston Bicycle and Pedestrian Committee, the Cincinnati 2012 Olympic Bid Committee, and the United States Canoe and Kayak Team Board of Directors. Hendrickson graduated from Hobart and William Smith College.

    Appointment of Audit Committee Chairperson

    By unanimous vote of the Board's five non-executive Independent Directors, David Deming was appointed Chairperson of the Company's Audit Committee, which follows the Board's October 1, 2021, unanimous consent to establish the Audit Committee. The Audit Committee currently consists of three non-executive Independent Directors, including Montel Williams, Joseph Watson, and David Deming.

    The Audit Committee was established to meet the up-listing requirements for a national securities exchange such as the NASDAQ or NYSE as soon as practicable, under NASDAQ Listing Rule 5605(c) and/or NYSE Listed Company Manual Sections 303A.06 and 303A.07.

    New Compensation Committee Member and Appointment of Compensation Committee Chairperson

    Also, by unanimous vote of the Board's five non-executive Independent Directors, Christina Jefferson was appointed to the Company's Compensation Committee, filling the vacancy left by former Director Leslie Bumgarner. This action follows the Board's October 1, 2021, unanimous consent to establish the Compensation Committee. The Compensation Committee currently consists of Independent Directors, Christina Jefferson, Montel Williams, and Joseph Watson. Additionally, the Board's five non-executive Independent Directors unanimously appointed Joseph Watson as Chairperson of the Compensation Committee.

    The Compensation Committee was established to meet the up-listing requirements for a national securities exchange such as the NASDAQ or NYSE as soon as practicable, under NASDAQ Listing Rule 5605(d) and/or NYSE Listed Company Manual Section 303A.05.

    Other Company Initiatives

    In addition to the aforementioned corporate governance initiatives, the Board celebrated the Company's recent uplisting to the OTCQB, reviewed the status of existing LOIs, discussed audits and other due diligence-related aspects of each pending acquisition, and estimated the internal timing of their respective Definitive Agreements.

    "I welcome the six initial members of the Company's newly formed Strategic Advisory Committee, and applaud the non-executive Independent Directors' appointments to the Audit and Compensation Committees,'' commented Ian James, Chief Executive Officer of Better For You Wellness Inc. "With Christina's vast experience in human capital, diversity, equity, and inclusion - her appointment to the Compensation Committee will offer a tremendous advantage to the Company. Furthermore, the appointments of David Deming and Joe Watson as the respective Audit and Compensation Committee Chairpersons bolsters BFYW's corporate governance."

    About Better For You Wellness, Inc.

    Better For You Wellness, Inc. (OTCQB:BFYW) is a Columbus, Ohio-based Company pursuing a dual buy-and-build model within the wellness industry. Better For You Wellness, Inc., through its wholly-owned subsidiary, builds and operates digitally-native, mission-driven brands within the clean beauty sector, including Better Suds. Better For You Wellness, Inc. is also under LOI to acquire three different companies within the clean and natural beauty category. Learn more at https://BFYW.com.

    Contact:

    Better For You Wellness, Inc.
    Ian James, CEO
    [email protected]

    Forward-Looking Statements

    This press release may contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including "could," "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" and the negative of these terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested in this report. Except as required by applicable law, we do not intend to update any of the forward-looking statements so as to conform these statements to actual results. Investors should refer to the risks disclosed in the Company's reports filed with SEC (https://www.sec.gov/).

    To view the source version of this press release, please visit https://www.newsfilecorp.com/release/113453

    Get the next $LEAF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LEAF
    $PBH
    $SPTN

    CompanyDatePrice TargetRatingAnalyst
    SpartanNash Company
    $SPTN
    2/19/2025$10.00Buy → Neutral
    Northcoast
    Prestige Consumer Healthcare Inc.
    $PBH
    12/9/2024$90.00Buy → Neutral
    Sidoti
    Prestige Consumer Healthcare Inc.
    $PBH
    6/21/2024$65.00 → $93.00Neutral → Buy
    DA Davidson
    SpartanNash Company
    $SPTN
    12/1/2022Neutral → Buy
    Northcoast
    Prestige Consumer Healthcare Inc.
    $PBH
    11/17/2022$71.00Buy
    Canaccord Genuity
    Prestige Consumer Healthcare Inc.
    $PBH
    5/10/2022$65.00 → $70.00Hold → Buy
    Jefferies
    Prestige Consumer Healthcare Inc.
    $PBH
    5/9/2022$63.00Perform → Outperform
    Oppenheimer
    SpartanNash Company
    $SPTN
    3/21/2022Neutral
    CL King
    More analyst ratings

    $LEAF
    $PBH
    $SPTN
    Leadership Updates

    Live Leadership Updates

    See more
    • SpartanNash Appoints New Independent Director as Part of Ongoing Board Refreshment

      Seasoned retail and grocery distribution executive Dorlisa Flur brings extensive strategic transformation expertise to the food solutions company GRAND RAPIDS, Mich., July 29, 2024  /PRNewswire/ -- Food solutions company SpartanNash (the "Company") (NASDAQ:SPTN) today announced that Dorlisa Flur has joined its Board of Directors (the "Board") as an independent director. Flur brings extensive experience in grocery distribution, retail, warehousing and logistics for multi-unit, multi-billion-dollar enterprises operating in public, private and private equity environments.   Flur

      7/29/24 8:30:00 AM ET
      $SPTN
      Food Distributors
      Consumer Discretionary
    • SpartanNash Welcomes John Taylor as Vice President and Associate General Counsel

      New hire strengthens leadership, further positions Company for strategic growth GRAND RAPIDS, Mich., April 16, 2024 /PRNewswire/ -- Food solutions company SpartanNash (the "Company") (NASDAQ:SPTN) today announced the appointment of John Taylor as Vice President and Associate General Counsel. Taylor will join the Company's best-in-class legal team as it seeks new market opportunities and advances toward its long-term growth goals. "John has earned the trust of his peers and clients for his strategic counsel and practical and innovative approach to conflict resolution in a dynam

      4/16/24 8:45:00 AM ET
      $SPTN
      Food Distributors
      Consumer Discretionary
    • SpartanNash Acquires Metcalfe's Market

      The food solutions company has acquired the three-store Wisconsin grocer, continuing employment for all Metcalfe's Market employees GRAND RAPIDS, Mich., April 15, 2024 /PRNewswire/ -- Food solutions company SpartanNash (the "Company") (NASDAQ:SPTN) today announced its acquisition of Metcalfe's Market, a three-store grocery chain in Wisconsin. Upon close of the sale, the Madison and Wauwatosa, Wis. locations will be continuing employment for all employees. The Metcalfe's Market storefront, branding and core shopper experience will remain in place. Founded in 1917 by Henry and T

      4/15/24 8:30:00 AM ET
      $SPTN
      Food Distributors
      Consumer Discretionary

    $LEAF
    $PBH
    $SPTN
    SEC Filings

    See more
    • SEC Form 10-K filed by Prestige Consumer Healthcare Inc.

      10-K - Prestige Consumer Healthcare Inc. (0001295947) (Filer)

      5/9/25 6:06:00 AM ET
      $PBH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Prestige Consumer Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Prestige Consumer Healthcare Inc. (0001295947) (Filer)

      5/8/25 6:04:33 AM ET
      $PBH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by SpartanNash Company

      SCHEDULE 13G/A - SpartanNash Co (0000877422) (Subject)

      4/15/25 12:18:00 PM ET
      $SPTN
      Food Distributors
      Consumer Discretionary

    $LEAF
    $PBH
    $SPTN
    Financials

    Live finance-specific insights

    See more
    • UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings

      Revenue of $296.5 million in Q4 and $1,137.8 million in fiscal 2025Organic revenue grew 7.9% in Q4 and 1.2% in fiscal 2025Diluted EPS of $4.29 in fiscal 2025; Adjusted fiscal 2025 Diluted EPS of $4.52 grew 7.4% versus adjusted prior yearReduced leverage to 2.4x at year-end driven by strong free cash flow and EBITDA growthInitial fiscal 2026 organic revenue growth and Diluted EPS outlook of approximately 1% to 2% and $4.70 to $4.82, respectively TARRYTOWN, N.Y., May 08, 2025 (GLOBE NEWSWIRE) --  Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2025. "We are very pleased with our fiscal year results, wh

      5/8/25 7:09:10 AM ET
      $PBH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings

      Revenue of $296.5 million in Q4 and $1,137.8 million in fiscal 2025Organic revenue grew 7.9% in Q4 and 1.2% in fiscal 2025Diluted EPS of $4.29 in fiscal 2025; Adjusted fiscal 2025 Diluted EPS of $4.52 grew 7.4% versus adjusted prior yearReduced leverage to 2.4x at year-end driven by strong free cash flow and EBITDA growthInitial fiscal 2026 organic revenue growth and Diluted EPS outlook of approximately 1% to 2% and $4.70 to $4.82, respectively TARRYTOWN, N.Y., May 08, 2025 (GLOBE NEWSWIRE) --  Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2025. "We are very pleased with our fiscal year results, which

      5/8/25 6:00:00 AM ET
      $PBH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results

      TARRYTOWN, N.Y., April 10, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 fourth quarter and year-end earnings release on Thursday, May 8, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10

      4/10/25 5:00:00 PM ET
      $PBH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $LEAF
    $PBH
    $SPTN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Macpherson Kerrie D. bought $19,450 worth of shares (1,000 units at $19.45), increasing direct ownership by 27% to 4,739 units (SEC Form 4)

      4 - SpartanNash Co (0000877422) (Issuer)

      6/7/24 4:32:26 PM ET
      $SPTN
      Food Distributors
      Consumer Discretionary

    $LEAF
    $PBH
    $SPTN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $LEAF
    $PBH
    $SPTN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $LEAF
    $PBH
    $SPTN
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $LEAF
    $PBH
    $SPTN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • SEC Form SC 13G filed by Prestige Consumer Healthcare Inc.

      SC 13G - Prestige Consumer Healthcare Inc. (0001295947) (Subject)

      2/14/24 10:11:25 AM ET
      $PBH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G filed by Prestige Consumer Healthcare Inc.

      SC 13G - Prestige Consumer Healthcare Inc. (0001295947) (Subject)

      2/14/24 7:09:49 AM ET
      $PBH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G/A filed by SpartanNash Company (Amendment)

      SC 13G/A - SpartanNash Co (0000877422) (Subject)

      2/13/24 5:14:03 PM ET
      $SPTN
      Food Distributors
      Consumer Discretionary
    • Chief Executive Officer Lombardi Ronald M. covered exercise/tax liability with 2,305 shares, decreasing direct ownership by 0.66% to 346,529 units (SEC Form 4)

      4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)

      5/9/25 5:46:21 PM ET
      $PBH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • EVP, Marketing & Sales Mekhail Adel covered exercise/tax liability with 457 shares, decreasing direct ownership by 2% to 20,908 units (SEC Form 4)

      4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)

      5/9/25 5:44:53 PM ET
      $PBH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: CFO & COO Sacco Christine was granted 7,775 shares and covered exercise/tax liability with 990 shares, increasing direct ownership by 13% to 58,465 units (SEC Form 4)

      4/A - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)

      5/9/25 5:43:10 PM ET
      $PBH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings

      Revenue of $296.5 million in Q4 and $1,137.8 million in fiscal 2025Organic revenue grew 7.9% in Q4 and 1.2% in fiscal 2025Diluted EPS of $4.29 in fiscal 2025; Adjusted fiscal 2025 Diluted EPS of $4.52 grew 7.4% versus adjusted prior yearReduced leverage to 2.4x at year-end driven by strong free cash flow and EBITDA growthInitial fiscal 2026 organic revenue growth and Diluted EPS outlook of approximately 1% to 2% and $4.70 to $4.82, respectively TARRYTOWN, N.Y., May 08, 2025 (GLOBE NEWSWIRE) --  Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2025. "We are very pleased with our fiscal year results, wh

      5/8/25 7:09:10 AM ET
      $PBH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings

      Revenue of $296.5 million in Q4 and $1,137.8 million in fiscal 2025Organic revenue grew 7.9% in Q4 and 1.2% in fiscal 2025Diluted EPS of $4.29 in fiscal 2025; Adjusted fiscal 2025 Diluted EPS of $4.52 grew 7.4% versus adjusted prior yearReduced leverage to 2.4x at year-end driven by strong free cash flow and EBITDA growthInitial fiscal 2026 organic revenue growth and Diluted EPS outlook of approximately 1% to 2% and $4.70 to $4.82, respectively TARRYTOWN, N.Y., May 08, 2025 (GLOBE NEWSWIRE) --  Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2025. "We are very pleased with our fiscal year results, which

      5/8/25 6:00:00 AM ET
      $PBH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SpartanNash and Special Olympics Team Up to Champion Midwest Athletes

      Campaign raises $265,000 to support local Special Olympics programs GRAND RAPIDS, Mich., April 29, 2025 /PRNewswire/ -- Food solutions company SpartanNash® (the "Company") (NASDAQ:SPTN) is proud to announce the success of its annual in-store fundraiser, which raised $265,000 for Special Olympics programs across nine states. The funds, donated by store guests, Associates and the SpartanNash Foundation, will help provide year-round support for thousands of athletes, empowering them to compete, train and thrive in inclusive sports environments.  "At SpartanNash, we are deeply com

      4/29/25 1:00:00 PM ET
      $SPTN
      Food Distributors
      Consumer Discretionary
    • SpartanNash downgraded by Northcoast with a new price target

      Northcoast downgraded SpartanNash from Buy to Neutral and set a new price target of $10.00

      2/19/25 8:33:28 AM ET
      $SPTN
      Food Distributors
      Consumer Discretionary
    • Prestige Consumer downgraded by Sidoti with a new price target

      Sidoti downgraded Prestige Consumer from Buy to Neutral and set a new price target of $90.00

      12/9/24 9:05:37 AM ET
      $PBH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Prestige Consumer upgraded by DA Davidson with a new price target

      DA Davidson upgraded Prestige Consumer from Neutral to Buy and set a new price target of $93.00 from $65.00 previously

      6/21/24 7:05:28 AM ET
      $PBH
      Biotechnology: Pharmaceutical Preparations
      Health Care